Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)
CNY 35.92
(-0.03%)
CNY 35.92
(-0.03%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 241.73 Million CNY | -6.42% |
| 2022 | 260.62 Million CNY | 6.75% |
| 2021 | 244.15 Million CNY | 22.82% |
| 2020 | 198.79 Million CNY | 73.27% |
| 2019 | 114.73 Million CNY | -23.07% |
| 2018 | 149.13 Million CNY | 100.81% |
| 2017 | 74.26 Million CNY | 88.42% |
| 2016 | 39.41 Million CNY | -5.08% |
| 2015 | 41.52 Million CNY | 35.24% |
| 2014 | 30.7 Million CNY | 139.68% |
| 2013 | 12.81 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 80.22 Million CNY | 147.13% |
| 2024 Q2 | 61.66 Million CNY | -23.13% |
| 2024 Q3 | 71.96 Million CNY | 16.69% |
| 2023 Q4 | 32.46 Million CNY | -51.36% |
| 2023 FY | 243.9 Million CNY | -6.42% |
| 2023 Q3 | 66.74 Million CNY | -12.67% |
| 2023 Q2 | 76.42 Million CNY | 11.93% |
| 2023 Q1 | 68.27 Million CNY | 37.43% |
| 2022 Q2 | 88.97 Million CNY | 55.17% |
| 2022 Q1 | 57.33 Million CNY | 51.12% |
| 2022 FY | 260.62 Million CNY | 6.75% |
| 2022 Q4 | 49.68 Million CNY | -23.13% |
| 2022 Q3 | 64.63 Million CNY | -27.36% |
| 2021 Q2 | 79.13 Million CNY | 68.74% |
| 2021 Q1 | 46.89 Million CNY | -16.42% |
| 2021 FY | 244.15 Million CNY | 22.82% |
| 2021 Q3 | 80.18 Million CNY | 1.33% |
| 2021 Q4 | 37.94 Million CNY | -52.68% |
| 2020 FY | 198.79 Million CNY | 73.27% |
| 2020 Q1 | 33.75 Million CNY | 166.69% |
| 2020 Q2 | 65.1 Million CNY | 92.88% |
| 2020 Q3 | 43.83 Million CNY | -32.67% |
| 2020 Q4 | 56.1 Million CNY | 28.0% |
| 2019 Q3 | 14.99 Million CNY | -73.54% |
| 2019 Q2 | 56.66 Million CNY | 86.29% |
| 2019 Q1 | 30.41 Million CNY | 0.0% |
| 2019 FY | 114.73 Million CNY | -23.07% |
| 2019 Q4 | 12.65 Million CNY | -15.59% |
| 2018 FY | 149.13 Million CNY | 100.81% |
| 2017 FY | 74.26 Million CNY | 88.42% |
| 2016 FY | 39.41 Million CNY | -5.08% |
| 2016 Q1 | 13.23 Million CNY | 51.84% |
| 2016 Q2 | 13.23 Million CNY | 0.0% |
| 2015 Q2 | 10.21 Million CNY | -0.0% |
| 2015 Q1 | 10.21 Million CNY | 0.0% |
| 2015 Q4 | 8.71 Million CNY | 0.0% |
| 2015 FY | 41.52 Million CNY | 35.24% |
| 2014 FY | 30.7 Million CNY | 139.68% |
| 2013 FY | 12.81 Million CNY | 0.0% |